Press Releases

Mediso Medical Equipment Developing and Service Ltd. is proud to announce the hundred and fiftieth installation of Mediso manufactured, integrated preclinical imaging systems, at the prestigious Edinburgh University.

Hyperscan is debuting at the 56th annual meeting of the American Society for Radiation Oncology (ASTRO), held September 14 – 16 in San Francisco.  Mevion representatives will formally introduce Hyperscan at booth 728 in the exhibit hall.

In findings that could eventually change the way breast cancer is treated, a study reports that the BluePrint genomic test provides more accurate information about the molecular subtype of breast cancer than does conventional IHC-FISH pathology testing.

In findings that may eventually change the way breast cancer is evaluated and treated, a new study reports that the BluePrint genomic test provides more accurate information about the molecular subtype of a specific breast cancer, compared to the use of conventional IHC-FISH pathology tests.

Radiant Sage LLC, a provider of on-demand clinical trial imaging infrastructure solutions, today announced that it has been named to CIOReview's list of 100 Most Promising Technology Companies. The CIOReview100 includes companies that are gaining momentum in the technology industry and making an impact.

FUJIFILM NAMED CATEGORY LEADER IN 2013 BEST IN KLAS: SOFTWARE AND SERVICES REPORT  Stamford, Conn., February 20, 2014 – FUJIFILM Medical Systems U.S.A., Inc. was recognized as the Category Leader for Radiology (Ambulatory) in the 2013 Best in KLAS: Software and Services report, published by KLAS Research.  SYNAPSE RIS, the advanced Radiology Information System on the market today, received the highest marks in the ambulatory radiology information systems category.  “We are honored by this recognition as it is based on the opinions and experiences of healthcare providers who rely on Fujifilm’s expertise and innovative solutions,” said Jim Morgan, vice president of Medical Informatics, FUJIFILM Medical Systems U.S.A., Inc. “At Fujifilm, we strive to go above and beyond our customers’ expectations.  We will continue to focus on quality, innovation and service to deliver the best solutions available.” The Category Leader award is given to the software and services vendor/solutions that have outperformed all others in their specific field. It is entirely based on provider feedback. Contributing to Fujifilm’s ranking was customer feedback and ratings on the product’s functional strengths. “We listened to the providers, and these are the results,” said Adam Gale, CEO and president of KLAS Research. “This report is a reflection of thousands of providers who wanted to be heard and counted. That is the reason top-performing vendors should be proud of their achievements.” Synapse RIS offers a host of features designed to meet the needs of outpatient facilities, radiology groups and hospitals. The system has also received EHR certification, enabling it to be part of the Meaningful Use initiative that provides financial incentives to medical professionals who use a certified EHR.  New this year is improved Synapse financials, patient portal and a new business analytics module. The annual report ranks the best-performing healthcare IT vendors in more than 100 market segments based on ratings from over 18,000 interviews with healthcare providers. KLAS evaluations are weighted in the following key areas: sales and contracting; implementation and training; service and support; and general and overall services. To see a demonstration of Fujifilm’s “Best in KLAS” product line at HIMSS, please register here: http://himss.fujimed.com. For more information visit, www.fujimed.com.   About KLAS KLAS is a research firm on a global mission to improve healthcare delivery by enabling providers to be heard and counted. Working with thousands of healthcare professionals and clinicians, KLAS gathers data on software, services, medical equipment, and infrastructure systems to deliver timely reports, trends, and statistical overviews. The research directly represents the provider voice and acts as a catalyst for improving vendor performance. Follow KLAS on Twitter at www.twitter.com/KLASresearch

NEW FUJIFILM SYNAPSE PATIENT-CENTRIC VNA SOLUTION HIGHLIGHTED AT 2014 HEALTHCARE INFORMATION & MANAGEMENT SYSTEMS SOCIETY (HIMSS) CONFERENCE & EXHIBIT Stamford, Conn., February 21, 2014 (Booth #4074) – FUJIFILM Medical Systems U.S.A., Inc., will unveil a patient-centric vendor neutral archive (VNA) for healthcare professionals at the 2014 annual meeting of the Healthcare Informatics Management Systems Society (HIMSS) conference and exhibit in Orlando, FL from February 23-27, 2014. Synapse VNA technology will catalog and maintain the data in a patient centric model allowing a single access point for EMRs and other systems.  “Patient healthcare requires communication and decision-making across care providers and settings,” said Jim Morgan, vice president of Medical Informatics, FUJIFILM Medical Systems U.S.A., Inc. “Fujifilm is pleased to introduce Synapse VNA, a new healthcare information technology platform that simplifies healthcare reporting and enables the healthcare community to have access to a complete patient record and streamlines workflow.” Multi-vendor environments are commonplace and Synapse VNA provides the platform to interface and integrate the data generated by these systems, and provide actionable intelligence. Synapse VNA will enhance image management, streamline workflow, reduce costs and, most importantly, improve patient care. It can be implemented within any environment and offers data access and availability.  The archive allows sharing and consolidation of the storage and provides secure access across all authorized users.  Synapse VNA provides a unified viewing experience for the VNA DICOM and non-DICOM data.  The Synapse VNA solution also embraces the importance of fast access to content through a zero download single viewing solution capable by displaying content within the VNA securely to desktop computers, mobile devices, or through EMR with Synapse Mobility. To see a demonstration at HIMSS, please register here: http://himss.fujimed.com. For more information visit: www.fujimed.com.

FUJIFILM SHOWCASES SYNAPSE PORTFOLIO AT 2014 HEALTHCARE INFORMATION & MANAGEMENT SYSTEMS SOCIETY (HIMSS) CONFERENCE & EXHIBIT Stamford, Conn., February 21, 2014 (Booth #4074) – FUJIFILM Medical Systems U.S.A., Inc., will be showing several new technologies at the 2014 annual meeting of the Healthcare Informatics Management Systems Society (HIMSS) conference and exhibit in Orlando, FL from February 23-27, 2014. Recognized globally as a premier conference in healthcare, HIMSS brings the industry’s brightest and most dynamic thought–leaders together to share ideas on the latest innovations in healthcare. “At HIMSS, Fujfilm will continue to deliver numerous benefits to providers by helping them to better synchronize information and workflows across multiple platforms with the Synapse portfolio,” said Jim Morgan, vice president of Medical Informatics, FUJIFILM Medical Systems U.S.A., Inc. “We’re helping healthcare systems everywhere from a broad range of organizations including small physician practices to large hospital systems. Our comprehensive solutions increase efficiency and enhance productivity.” Visit HIMSS booth #4074 to learn more about Fujifilm’s offerings through live demonstrations and opportunities for face-to-face conversations. Following is a summary of offerings: The cornerstone of Fujifilm’s integrated solution is Synapse PACS. Two main goals – enhanced communication and optimized productivity for radiologists in any imaging environment – were the impetus behind its development. Also to be showcased is the advanced Synapse Cardiovascular, a web-based platform uniquely suited to fit into any facility’s I.T. infrastructure. It creates finalized, signed cardiovascular-structured reports quickly and easily. Advanced tools that help quantify results, such as interactive diagrams and freehand drawing tools, add to its advantages. It can be optimized for cardiac catheterization, invasive peripheral vascular, echocardiography, nuclear cardiology, vascular ultrasound and cardiac CT and MRI procedures. Radiologists and cardiologists interested in advanced visualization and analysis will find the innovations of Fujifilm’s Synapse 3D very appealing for their diagnostic needs with twenty nine functions to choose from. It is fully integrated with Synapse PACS and Synapse Cardiovascular, and eliminates the need to access advanced diagnostic tools from a separate workstation or with a separate login. Patient lists are synchronized, making it up to date at all times. The next generation of Synapse RIS, the most advanced Radiology Information System on the market today, will also be shown. Synapse RIS offers a host of features designed to meet the needs of outpatient facilities, radiology groups and hospitals. The system has also received EHR certification, enabling it to be part of the Meaningful Use initiative that provides financial incentives to medical professionals who use a certified EHR.  New this year is improved Synapse financials, patient portal and a new business analytics module. Fujifilm has also announced the integration of vendor neutral architecture (VNA) into its Synapse portfolio. Synapse VNA enables the management and distribution of DICOM and non-DICOM information from a variety of PACS providers.  IT professionals will appreciate the Information Lifecycle Management (ILM) features, multiple domain/organization structure access controls, virtualized platform and Oracle Enterprise Edition (EE) database. Fujifilm will also share the benefits of its zero footprint mobile application, Synapse Mobility. The application enables access to Fujifilm’s suite of Synapse products from hand-held devices, in addition to browser independence. Access to non-DICOM information from the Synapse VNA has been added to complete the universal viewing capability from EMRs such as Epic Hyperspace.  Synapse Mobility continues to lead in diagnostic capability as demonstrated by having a 510(k) from the FDA for both browser and mobile versions. To see a demonstration at HIMSS, please register here: http://himss.fujimed.com. For more information visit: www.fujimed.com.  About Fujifilm FUJIFILM Medical Systems U.S.A., Inc. is a leading provider of diagnostic imaging products and medical informatics solutions to meet the needs of healthcare facilities today and well into the future. From an unrivaled selection of digital x-ray systems, to the Synapse® brand of PACS, RIS and cardiovascular products, to advanced women’s health imaging systems, Fujifilm has products that are ideal for any size imaging environment. The Endoscopy Division of FUJIFILM Medical Systems U.S.A., Inc. supplies high quality, technologically advanced FUJINON brand endoscopes to the medical market. FUJIFILM Medical Systems U.S.A., Inc. is headquartered in Stamford, CT. For more information please visit www.fujimed.com and www.fujifilmendoscopy.com .  

FUJIFILM PRESENTS INTEGRATED SYNAPSE PORTFOLIO TO OPTIMIZE WORKFLOW AND IMPROVE PATIENT CARE AT ACC 2014 Stamford, Conn., March 27, 2014 (Booth #2921 - Hall B) –FUJIFILM Medical Systems U.S.A., Inc. will highlight an integrated Synapse portfolio that allows cardiologists  and clinical professionals to enhance patient care through optimized productivity at the 63rd Annual Scientific Session & Expo of the American College of Cardiology (ACC) on March 29 - 31 in Washington, DC.  “Cardiology departments need solutions that will improve workflow. Fujifilm offers advanced features and exceptional images to accelerate workflow and enhance diagnostic confidence,” said Jim Morgan, vice president of Medical Informatics, FUJIFILM Medical Systems U.S.A., Inc. “With Synapse, our customers are able to perform their job more efficiently and ultimately allows them to concentrate more on the patient and improve overall patient outcomes.” Following is a summary of offerings:Synapse Cardiovascular helps cardiologists in a variety of clinical areas efficiently and confidently interpret exceptional images with streamlined workflow, image review and reporting. With full image management and reporting capabilities, and tools designed specifically for nuclear cardiology, vascular ultrasound, ECG management, echocardiography, cardiac catheterization, CT, and Cardiac MRI workflows, Fujifilm's Synapse Cardiovascular is an essential addition to any clinical workplace. Cardiologists interested in advanced visualization and analysis will find the innovations of Fujifilm’s Synapse 3D very appealing for their diagnostic needs with twenty nine functions to choose from. It is fully integrated with Synapse PACS and Synapse Cardiovascular, and eliminates the need to access advanced diagnostic tools from a separate workstation or with a separate login. Patient lists are synchronized, making it up to date at all times. Also to be introduced is Synapse Analytics, an advanced tool that provides critical, timely data to assist decisions made by healthcare professionals about clinical operations and financial performance. This is a single application for use across the Synapse PACs, RIS, and CV platforms and allows the user to build, manipulate, and monitor a full suite of Business Intelligence dashboards and reports. To register for a product demonstration at ACC, please visit: http://www.fujimed.com/gateway/acc/2014/pacs.asp . For more information about Synapse, please visit: http://cardiovascular.fujimed.com/  About Fujifilm FUJIFILM Medical Systems U.S.A., Inc. is a leading provider of diagnostic imaging products and medical informatics solutions to meet the needs of healthcare facilities today and well into the future. From an unrivaled selection of digital x-ray systems, to the Synapse® brand of PACS, RIS and cardiovascular products, to advanced women’s health imaging systems, Fujifilm has products that are ideal for any size imaging environment. The Endoscopy Division of FUJIFILM Medical Systems U.S.A., Inc. supplies high quality, technologically advanced FUJINON brand endoscopes to the medical market. FUJIFILM Medical Systems U.S.A., Inc. is headquartered in Stamford, CT. For more information please visit www.fujimed.com  and www.fujifilmendoscopy.com .

FUJIFILM PRESENTS LATEST HEALTHCARE IT TECHNOLOGIES AT 2014 SOCIETY FOR IMAGING INFORMATICS IN MEDICINE (SIIM) Stamford, Conn., May 12, 2014 (Booth #330-334) – FUJIFILM Medical Systems U.S.A., Inc., will present its comprehensive Synapse portfolio for IT professionals at the 2014 annual meeting of the Society for Imaging Informatics in Medicine (SIIM) in Long Beach, California from May 15-17, 2014. The Synapse family of products combined provides management of the complete patient record, ensuring diagnostic integrity while providing fast, secure access to clinical users via web platforms or mobile devices. “Integration of all imaging types and formats with the EMR from a centralized repository is rapidly underway,” said Jim Morgan, vice president of Medical Informatics, FUJIFILM Medical Systems U.S.A., Inc. “This trend has led to the adoption of Synapse VNA and Mobility in some of the largest hospital networks in the country.” Visit SIIM booth #330-334 to learn more about Fujifilm’s offerings through live demonstrations and opportunities for face-to-face conversations. Following is a summary of offerings: The cornerstone of Fujifilm’s integrated solution is Synapse PACS. Two main goals – enhanced communication and optimized productivity for radiologists in any imaging environment – were the impetus behind its development.  The next generation of Synapse RIS, the most advanced Radiology Information System on the market today, will also be shown. Synapse RIS and PACS integrate seamlessly, allowing the radiologist to see scanned documents and history from within the PACS, and allowing the user to see images from within the RIS. The system has also received EHR certification, enabling it to be part of the Meaningful Use initiative that provides financial incentives to medical professionals who use a certified EHR.   Fujifilm has also announced the integration of vendor neutral architecture (VNA) into its Synapse portfolio. Synapse VNA provides the platform to interface and integrate the data generated by these systems, and provide actionable intelligence. Synapse VNA will enhance image management, streamline workflow, reduce costs and, most importantly, improve patient care. It can be implemented within any environment and offers data access and availability.  The archive allows sharing and consolidation of the storage and provides secure access across all authorized users.   Synapse VNA provides a unified viewing experience for the VNA DICOM and non-DICOM data. The Synapse VNA solution also embraces the importance of fast access to content through a zero download single viewing solution capable by displaying any content within the VNA securely to any desktop, mobile device, or through EMR with Synapse Mobility. For more information visit: www.fujimed.com.

Superb micro-vascular imaging helps clinicians deliver a more accurate diagnosis. Toshiba is making it possible for clinicians to use ultrasound to see the smallest vessels in and around areas like tumors and lymph nodes, giving them a new way to diagnose disease faster and non-invasively.

SAN ANTONIO, July 30, 2014 /PRNewswire/ -- GenSpera, Inc. (OTCQB: GNSZ), a leader in developing prodrug therapeutics for the treatment of cancer, announces the issuance of a United States patent entitled "Methods and compositions for the detection of cancer". The patent US 8,772,226 B2 was issued July 8, 2014.

IBA (Ion Beam Applications SA), the world's leading provider of proton therapy solutions for the treatment of cancer, announces today that it has received combined clearances from the U.S. Food and Drug Administration (FDA) that will enable IBA to market-launch the Proton Therapy specific Cone Beam Computed Tomography (CBCT) solution.

MINNEAPOLIS and SEATTLE — (July 29, 2014) vRad (Virtual Radiologic) the largest U.S. telemedicine company and radiology practice with over 450 physicians, and Remote Medical International® (RMI), a leading provider of global medical support services for remote locations, announced today that vRad is providing 24x7 emergent teleradiology services for RMI’s medical staff supporting the U.S. Military in Afghanistan and Kuwait.

Based on its recent analysis of the breast imaging systems market, Frost and Sullivan recognizes Gamma Medica with the 2014 Global Frost and Sullivan Award for Product Leadership.

UltraSpect, provider of the only multi-vendor and most cost-effective imaging solution for meeting the American Society of Nuclear Cardiology (ASNC) low dose guidelines, announces today that Henry Ford Wyandotte Hospital in Michigan has upgraded its nuclear medicine (NM) image reconstruction software to UltraSpect Xpress3.Cardiac. As a result, all patients receiving NM exams now have exams in half the time, with half the dose, regardless of the model or age of camera being used.

Lantheus Holdings, parent company to Lantheus Medical Imaging, a global leader in developing, manufacturing, selling and distributing innovative diagnostic imaging agents, announced today that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission relating to a proposed initial public offering of its common stock. Lantheus Holdings intends to apply to list its common stock on the NASDAQ Global under the ticker symbol "LNTH." The number of shares to be offered and the price range of the proposed offering have not yet been determined. Lantheus Holdings expects to use the net proceeds of the offering to repay indebtedness of LMI and for working capital and general corporate purposes.

 FUJIFILM MEDICAL SYSTEMS U.S.A., INC. DEMONSTRATES LATEST INNOVATIONS IN ECHOCARDIOGRAPHY IMAGE MANAGEMENT AND REPORTING AT THE 25th ANNUAL SCIENTIFIC SESSIONS OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY Stamford, Conn., June 19, 2014 (Booth #301) – FUJIFILM Medical Systems U.S.A., Inc. will demonstrate the next generation of Synapse Cardiovascular, that will allow cardiologists and clinical professionals to enhance patient care through advanced reporting applications  at the 25th Annual Scientific Session of the American Society of Echocardiography in Portland, Oregon. “With Synapse, our users are able to perform their job more efficiently and ultimately allow them to concentrate more on the patient and improve patient outcomes,” said Jim Morgan, vice president of Medical Informatics, FUJIFILM Medical Systems U.S.A., Inc. “At ASE, we will demonstrate an upcoming clinical reporting platform that will feature a new user interface and layout options that has the potential to benefit your entire practice.” Following is a summary of offerings:Synapse Cardiovascular helps cardiologists in a variety of clinical areas efficiently and confidently interpret images and compose structured reports with a streamlined workflow. The system has powerful capabilities designed specifically for, echocardiography, cardiac catheterization and invasive peripheral vascular, nuclear cardiology, vascular ultrasound, ECG management, CT, and Cardiac MRI workflows. Fujifilm's Synapse Cardiovascular is an essential addition to any clinical workplace.  At the show, attendees will also be able to see a works-in-progress demonstration of Synapse Cardiovascular 6.0*, which will showcase intended future functionality for echocardiography. Fujifilm will also share the benefits of its zero footprint mobile application, Synapse Mobility. The application enables access to Fujifilm’s suite of Synapse products from hand-held devices, in addition to browser independence. Access to non-DICOM information from the Synapse VNA has been added to complete the universal viewing capability from EMRs such as Epic Hyperspace.  Synapse Mobility continues to demonstrate its diagnostic capability for both browser and mobile versions. To register for a demonstration at ASE 2014, please visit: http://www.fujimed.com/gateway/ase/2014/registration.html.  *Synapse Cardiovascular 6.0 will be made commercially available in the U.S. upon receipt of FDA clearance For more information about Synapse, please visit: http://cardiovascular.fujimed.com/

Together, the American Society for Radiation Oncology (ASTRO) and the American Association of Physicists in Medicine (AAPM) will share details about RO-ILS: Radiation Oncology Incident Learning System, a new, national patient safety initiative to facilitate safer and higher quality radiation oncology care.

During the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, GE Healthcare introduced its Discovery IQ PET/CT system, enabling both outstanding image quality and intelligent quantitation, helping physicians deliver the best possible patient outcomes.

The U.S. Food and Drug Administration today approved a new use for Lymphoseek (technetium 99m tilmanocept) Injection, a radioactive diagnostic imaging agent used to help doctors determine the extent a type of cancer called squamous cell carcinoma has spread in the body’s head and neck region.